Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Tizanidine Use in Pelvic Reconstructive Surgery
NCT07766837Phase 2Recruiting
- Sponsor
- Hartford Hospital
- Start
- Aug 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tizanidine in postoperative pain (2 arms), sponsored by Hartford Hospital. Primary endpoint: Patient Reported Outcome. Started Aug 2026; status: recruiting.
02
Drugs
tizanidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07766837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07766837.